Dr. Jan Schaefer, a dedicated researcher at WEHI, is on a mission to revolutionize the treatment of chronic obstructive pulmonary disease (COPD). His passion lies in developing innovative therapeutics, particularly in the realm of targeted drug delivery. With a focus on macrophages, the immune cells that play a dual role in COPD, Dr. Schaefer aims to minimize side effects and maximize precision in RNA therapies.
What sets Dr. Schaefer's work apart is his approach to combating infectious and inflammatory diseases. Unlike traditional battles against pathogens, his research is more akin to outmaneuvering an opponent. By studying the complex mechanisms of these diseases, he seeks to develop new defense systems, making the fight against COPD a strategic endeavor.
His collaboration with Dr. Marcel Doerflinger and Dr. Lee Booty at WEHI has been instrumental in his success. Dr. Doerflinger, his former lab mentor and now lab head, has not only shaped his scientific thinking but also encouraged his ambitions. Dr. Booty, a venture principal scientist, has provided invaluable guidance in bridging the gap between academia and industry.
The highlight of Dr. Schaefer's career was winning the InnoVision competition in 2025. This achievement not only brought a travel stipend but also opened doors for collaboration with industry partners. Presenting his research at academic conferences and engaging with industry events has been a rewarding experience, allowing him to showcase his work on a global stage.
However, Dr. Schaefer's journey hasn't been without challenges. Starting his PhD remotely during the COVID-19 pandemic presented unique obstacles. Yet, his perseverance and the supportive environment at WEHI have been instrumental in overcoming these hurdles.
Outside the lab, Dr. Schaefer finds solace in exercise and exploring Melbourne's vibrant cafe culture. His passion for scientific exploration and collaboration drives him to make a meaningful impact in the field of respiratory health, offering hope for those affected by COPD.
